Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDL70
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,843
Award facts
- Contract value 100% obligated
- $122,843.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials with a ceiling value of $122,843.40. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a procurement of this oncology medication to support Department of Defense healthcare facilities. The award carries no set-aside designation, demonstrating that DMS Pharmaceutical Group competed effectively in the open federal market leveraging its established capabilities and woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. Under this comprehensive pharmaceutical supply agreement, the DLA issues firm fixed-price delivery orders for a broad range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group's positioning as a critical supplier within the federal pharmaceutical supply chain reflects its established track record of delivering specialized pharmaceutical products, including oncology treatments and other high-value medications, directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FDL70?
SPE2DB25FDL70 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FDL70 worth?
The government has obligated $122,843 on SPE2DB25FDL70.
Is contract SPE2DB25FDL70 an order under another contract?
Yes. SPE2DB25FDL70 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL70 competed?
The extent of competition for SPE2DB25FDL70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award